Amendola's Lab
@marioamendola1
Followers
148
Following
115
Media
5
Statuses
67
Dr Amendola Mario, Ph.D., is an expert in the development and applications of gene therapy and genome editing for treating human genetic diseases.
Evry, Paris suburbs
Joined January 2012
Are you planning a career change after the summer break? My group is looking for postdocs with expertise in hematopoietic stem cells and muscle for developing novel gene therapy approaches. Thanks for sharing these positions within your network https://t.co/EgTsJt3zQI
0
8
11
🎉 Excited to share our new paper: "Advanced Imaging and Cytometric Techniques to Characterize Lipid Accumulation in Wolman Disease" 📄✨ https://t.co/8REeGLZB75
onlinelibrary.wiley.com
Wolman disease (WD) is a severe lysosomal storage disorder characterized by fatal lipid accumulation caused by the deficiency of a lipid metabolic enzyme, Lysosomal Acid Lipase (LAL), involved in...
0
0
1
stunning Sorrento for an exciting conference on CRISPR and genome editing! Top scientists, cutting-edge talks, and unforgettable views 🌊🧬 Don’t miss it – details here 👉 https://t.co/AUr9p86sxp
meetings.embo.org
A decade of groundbreaking research on bacterial CRISPR-Cas defence systems has culminated in the development of revolutionary editing technologies. This tool has been exploited to create transgenic …
0
2
1
MAGIC aims to develop effective treatments for people with rare #MuscularDystrophy. These rare conditions affect the muscles and can impact walking, eating, sleeping and breathing. By bringing together leading experts we will push research forwards, faster.🧑🔬 #RareDiseaseDay
1
5
4
🌍💜💛RARE DISEASE DAY @Frederic_Revah , CEO of @GenethonFr, gave an interview to @davidwild77, @Citeline reporter, about the role of non-profit organizations in medical research for rare diseases. @rarediseaseday Full article 👉 https://t.co/3L4AQWkkQB
insights.citeline.com
Nonprofits are finding new ways to address market gaps and develop treatments for rare diseases with little commercial attraction.
0
3
2
Happy to contribute to the European Rare Disease Research Alliance!
The European Rare Diseases Research Alliance @ERDERA_org kicks off with a bold vision to make Europe a global leader in rare diseases research and innovation. 🚀 Read press release🗞️ https://t.co/8hvRh9CNQE 🌍💙 #ERDERA #RareDiseases
@EUScienceInnov @HorizonEU @Inserm
0
1
4
Looking for exciting new opportunities? Check out the new positions on gene therapy and genome editing available in our lab! https://t.co/3zeMlPLOwz!
lnkd.in
This link will take you to a page that’s not on LinkedIn
0
6
4
We are proud to announce that @IMMolecular (iMM) joins the MAGIC Consortium to advance research on muscular dystrophies. With iMM's expertise, MAGIC will enhance muscle-on-chip models and develop new genetic therapies. 🤝 Welcome on board! Learn more: https://t.co/5gIil1FAtB
0
2
4
🔬 Join our research lab @sorrentinolab! We have an exciting PhD position available for passionate minds eager to explore cutting-edge disease models. Apply now!!! PhD in personalized medicine and innovative therapies👩🔬🧑🔬🧬🧪
‼ Dottorati di Ricerca 2024/25: aperte le iscrizioni ai concorsi. ⏰ Domanda di ammissione entro il 13 giugno. Info ► https://t.co/L2gyA9LVN8 ———— ‼ PHD Research Doctorates 2024/25: calls for applications are open. ⏰ Applications by June the 13th.
0
4
10
The backstage of our photo shooting session! Thanks to the studio Yann Arthus Bertrand for offering this opportunity to our lab and #Genethon. Eager to see the final result!
1
1
6
Presenting out poster on novel idlv template for targeted integration! Today at the @ASGCTherapy #asgct2024
0
3
13
Happy to see Marine Laurent presenting or new data on gene therapy of Woman disease at the #ASGCT2024
0
0
10
Thank you @EU_HaDEA for organizing this great meeting. Now it's #Beertime for coordinators ;-). An excellent way to develop collaborations between @MAGIC_horizon and @DreamsPjt_EU Cc @marioamendola1 @GenethonFr @IStemFrance
0
1
12
New positions are available in our lab! https://t.co/WOv9p1hc73
0
2
2
Are you planning a career change after the summer break? My group is looking for postdocs with expertise in hematopoietic stem cells and muscle for developing novel gene therapy approaches. Thanks for sharing these positions within your network https://t.co/EgTsJt3zQI
0
8
11
Are you planning a career change after the summer break? My group is looking for postdocs with expertise in hematopoietic stem cells and muscle for developing novel gene therapy approaches. Thanks for sharing these positions within your network https://t.co/X1USPni5FY
linkedin.com
Are you planning a career change after the summer break? My group is looking for postdoctoral fellows with expertise in hematopoietic stem cells and muscle for developing novel gene therapy approac...
0
5
6
In honour of #BlueBeetle movie on @AMCTheatres i’ve just made this with #leonardoai, not really accurate with the real character but in my opinion it’s a nice results anyway 🙂 what you think? 🐒
1
2
4
Base editors have never been easier to use in zebrafish @Marion_Rosello
nature.com
Nature Protocols - The authors provide a protocol for cytosine base editing to introduce precise substitutions into the genome of zebrafish, an important model for genetic studies and in vivo...
5
32
93
With 15 partners from nine countries, @MAGIC_horizon will research therapies for #musculardystrophies. Led by Prof Francesco Saverio Tedesco @uclbiosciences @TheCrick and Prof Mario Amendola @Inserm @GenethonFr
@Frances91557638 @marioamendola1
https://t.co/7AFScJ68RD
ucl.ac.uk
An international project to find new treatments for muscular dystrophy, led by a UCL researcher, has been awarded a €9.5 million (£8 million) grant from Horizon Europe and UKRI.
0
4
10